A six-panel PCR of both plasma and blood for EBV-DNA as tumor marker for nasopharyngeal carcinoma patients treated in the United States

被引：0
|
作者：
Weiss, J.
Xavier, M.
Tsai, D.
Arnoldi, S.
Sherman, E.
机构：
[1] Hosp Univ Penn, Philadelphia, PA 19104 USA
[2] ViraCor Labs, Lees Summit, MO USA
[3] Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2009年 / 27卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e17014
引用
收藏
页数：2
相关论文
共 11 条
  • [1] EBV-DNA in the peripheral blood and HLA class II typing in Greek patients with nasopharyngeal carcinoma
    Karanikiotesh, Charisios
    Kariotis, Nikolaos
    Bakoyiannis, Charalambos
    Georgakopoulos, Eleftherios
    Krommidas, Argirios
    Danillidis, Michail
    Kosmidis, Paris
    Fountzilas, George
    [J]. ANNALS OF ONCOLOGY, 2004, 15 : 141 - 141
  • [2] A New and Precise Method for Quantitative Detecting Cell Free EBV-DNA in the Plasma of Patients With Nasopharyngeal Carcinoma
    Lin, Q.
    Hu, B.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2016, 96 (02): : E353 - E353
  • [3] Changes in plasma EBV-DNA and immune status in patients with nasopharyngeal carcinoma after treatment with intensity-modulated radiotherapy
    Qi Chen
    Wei Hu
    Huacai Xiong
    Shenpeng Ying
    Yanyun Ruan
    Bo Wu
    Hongsheng Lu
    [J]. Diagnostic Pathology, 14
  • [4] Changes in plasma EBV-DNA and immune status in patients with nasopharyngeal carcinoma after treatment with intensity-modulated radiotherapy
    Chen, Qi
    Hu, Wei
    Xiong, Huacai
    Ying, Shenpeng
    Ruan, Yanyun
    Wu, Bo
    Lu, Hongsheng
    [J]. DIAGNOSTIC PATHOLOGY, 2019, 14 (1)
  • [5] Analysis of Plasma EBV-DNA and Soluble Checkpoint Proteins in Nasopharyngeal Carcinoma Patients after Definitive Intensity-Modulated Radiotherapy
    Ruan, Yanyun
    Hu, Wei
    Li, Wanhong
    Lu, Hongsheng
    Gu, Huamin
    Zhang, Ying
    Zhu, Chumeng
    Chen, Qi
    [J]. BIOMED RESEARCH INTERNATIONAL, 2019, 2019
  • [6] Plasma EBV DNA as a Predictive Biomarker in Patients With Endemic Nasopharyngeal Carcinoma Treated With Induction Chemotherapy and Concurrent Chemoradiation Therapy
    Chua, M.
    Sze, O. Whee
    Wee, J.
    Soong, Y.
    Lim, D.
    Tan, T.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2014, 90 : S120 - S121
  • [7] Pediatric and young adult (<21) non-metastatic nasopharyngeal carcinoma patients treated with neoadjuvant cisplatin and docetaxel chemoradiotherapy with plasma EBV DNA quantification
    Varan, Ali
    Ozyar, Enis
    Gultekin, Melis
    Corapcioglu, Funda
    Koksal, Yavuz
    Aydin, Burca
    Akyuz, Canan
    Buyukpamukcu, Munevver
    [J]. PEDIATRIC BLOOD & CANCER, 2007, 49 (04) : 484 - 484
  • [8] Pediatric and young adult (<21) non-metastatic nasopharyngeal carcinoma (NPC) patients treated with neoadjuvant cisplatin and docetaxel (CD) chemoradiotherapy with plasma EBV DNA quantification
    Varan, A.
    Ozyar, E.
    Gultekin, M.
    Corapcioglu, F.
    Koksal, Y.
    Aydin, B.
    Akyuz, C.
    Buyukpamukcu, M.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [9] Use of plasma Epstein-Barr virus DNA monitoring as a tumor marker in follow-up of patients with nasopharyngeal carcinoma:: Preliminary results and report of two cases
    Oezyar, E.
    Gueltekin, A.
    Alp, A.
    Hascelik, G.
    Ugur, Oe.
    Atahan, I. L.
    [J]. INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS, 2007, 22 (03): : 194 - 199
  • [10] A new circulating plasma/serum Epstein-Barr virus (EBV) DNA test by locked nucleic acid (LNA) PCR technique with enhanced sensitivity in diagnosis & monitoring of patients suffering from nasopharyngeal carcinoma (NPC) and other EBV associated malignancies
    Yip, Timothy T. C.
    Kwok, Hazel Y. Y.
    You, Sharon S. Y.
    Kwong, Dora L. W.
    Fong, Alvin H. W.
    Cheng, W. W.
    Lai, Christopher
    Shek, Anthony C. C.
    Ma, Victor W. S.
    LiLung, Maria
    Ngan, Roger K. C.
    [J]. CANCER RESEARCH, 2016, 76
12